Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- Spread of Vector-borne Diseases, Associated Arthralgias, a Concern For Rheumatologists
-
- Cimzia Labeling Change Addresses Concerns for Use During Pregnancy
- Experts Suggest Trump Declare Opioid Epidemic a ‘National Emergency’
- One-third of Patients With PsA Report Barriers to Biologic Access
- Prescription Opioids Decrease by Almost 30%
- FUTURE 3: Self-administered Cosentyx Safe, Efficacious in PsA
- FUTURE 5: Subcutaneous Cosentyx Effective Against PsA at Week 24
- TNF Inhibitors Effective in AS, PsA Over 3-year Period
- Women With RA, Psoriasis at Increased CV Risk
-
- FDA Advisory Committees Back CV Safety of Celebrex for OA, RA
- FDA Arthritis Advisory Committee Votes in Favor of Olumiant 2 mg for RA
- FDA Declines Proposed Rituxan, Herceptin Biosimilars From Celltrion
- Filgotinib for RA Improves Patient-Reported Quality of Life
- Samsung Bioepis, AbbVie settle Lawsuit Over Humira Biosimilar
- Sandoz Obtains Positive CHMP Opinion for Remicade Biosimilar
- The Rheumatology-Infectious Disease Clinic: A Much Needed Addition to Interprofessional Rheumatologic Care Leonard H. Calabrese, DO
- Ace the Case: A 72-Year-Old Woman With Several Weeks of Pain and Stiffness in Her Shoulders, Neck, and Pelvic Region
-
- Concerns Over Nonmedical Switching of Biologics Spur Physician Guidelines
- Long-term Humira Sustains Improvements in Axial Spondyloarthritis
- MRI-detected Erosions Do Not Specify RA
- Reproductive, Hormonal Factors Linked to Knee OA Risk in Women
- Smaller, Shorter Trials, More Flexibility Needed for Lupus Treatment Development
- Tai Chi Improves Fibromyalgia Pain
- VIDEO: Coding Awareness Critical to Success in ‘New World Order’ of Value-Based Health Care
- Controversy Persists for Palindromic Rheumatism: RA Precursor or Distinct Entity?
-
- Ease New Medicare Beneficiary Card Transition Through Staff Education
- Independent Rheumatologists Must ‘Find Harmony’ With Payers
- VIDEO: Rheumatologists Need ‘a Seat at the Table’ in Patient Care Discussions With Payers
- VIDEO: Despite ‘Revolutionary’ Potential for Health Care, Biologics Remain Costly, Limited Availability
- Vitamin D Supplementation Not Ready for Prime Time in Rheumatic Diseases
- ACR Disappointed by CMS Final Rule on Essential Health Benefits
- Experts Express Concerns About FDA Precertification Program for Health Apps